Latest news
Silence Therapeutics Jumps Over 25% After Divesiran Phase 2 Trial Supports 12-Week Dosing - TechStock²TechStock² · Mon, 10 Aug 2026 20:28:54 GMTEuropean Commission Approves 7.2 mg Once-Weekly Wegovy Dose for Adults With Obesity - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 19:52:06 GMTOutcomes in Early-Stage Triple-Negative Breast Cancer With Dose-Dense Doxorubicin and Cyclophosphamide as Part of Pembrolizumab-Based Regimens - Journal of Hematology Oncology PharmacyJournal of Hematology Oncology Pharmacy · Fri, 07 Aug 2026 16:18:45 GMTOnce-weekly HIV pill as effective as daily dose, research shows - The ConversationThe Conversation · Wed, 05 Aug 2026 16:05:51 GMT